Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients

Lyons, MA

Lyons, MA (reprint author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019; 63 (12):

Abstract

Pretomanid (PA-824) is a nitroimidazole in clinical testing for the treatment of tuberculosis. A population pharmacodynamic model for pretomanid was d......

Full Text Link